GIRENTUXIMAB
UNII 539B57DFJF

Substance Identification & Data

This profile provides standardized clinical and technical data for Girentuximab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 539B57DFJF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 916138-87-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
539B57DFJF
CAS Registry Number
916138-87-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
GIRENTUXIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
9116
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
WW-150
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Girentuximab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GIRENTUXIMAB

Common Names & Synonyms

GIRENTUXIMAB [INN]
GIRENTUXIMAB [MART.]
GIRENTUXIMAB [USAN]
GIRENTUXIMAB [WHO-DD]

Brand / Trade Names

RENCAREX

Technical Codes

CA9-SCAN CG250
CG250
CG-250
WX-G250